JQ1 in combination with cyclin-dependent kinase 7 (CDK7) inhibitor THZ1 loaded in polyester NPs was reported as an effective molecular therapeutic option for the treatment of pancreatic ductal adenocarcinoma (PDAC) [33]. Here, CDK7 is linked to pancreatic ductal adenocarcinoma.